Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome

Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome

Brain tumors are the most common solid neoplasms of childhood, but they are very rarely reported in children with Down Syndrome (DS), who develop more commonly different types of malignancies. In particular, we hereby report the case of an 8-years-old child with DS that presented to our attention fo...

Full description

Bibliographic Details
Main Authors: Giuseppe Petruzzellis, Diletta Valentini, Francesca del Bufalo, Giulia Ceglie, Andrea Carai, Giovanna Stefania Colafati, Emanuele Agolini, Francesca Diomedi-Camassei, Tiziana Corsetti, Iside Alessi, Angela Mastronuzzi, Franco Locatelli, Antonella Cacchione
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Oncology
Subjects:
brain tumor
down syndrome
BRAF V600E mutation
pleomorphic xanthoastrocytoma
vemurafenib
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00277/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00277/full

Similar Items